Clinical Trial Update: CP-461 in the Treatment of Patients With Advanced Melanoma [Phase 2]

View source ↗

Summary

The Phase 2 trial of CP-461 for advanced melanoma has been terminated. No results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CP-461

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Malignant Melanoma | Phase 2 | Status: TERMINATED